DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aplisol (Tuberculin) - Published Studies

 
 



Aplisol Related Published Studies

Well-designed clinical trials related to Aplisol (Tuberculin)

The comparative performance of the single intradermal comparative tuberculin test in Irish cattle, using tuberculin PPD combinations from different manufacturers. [2011.07.05]

Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and co-infections. [2010.08]

Interpreting tuberculin skin tests in a population with a high prevalence of HIV, tuberculosis, and nonspecific tuberculin sensitivity. [2010.05.01]

The effect of tuberculin testing on the development of cell-mediated immune responses during Mycobacterium bovis infection. [2006.11.15]

The effect of Johne's vaccination on tuberculin testing in farmed red deer (Cervus elaphus). [2005.08]

BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? [2003.06.20]

Effect of zinc on the tuberculin response of children exposed to adults with smear-positive tuberculosis. [2002.12]

BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. [2001.11.12]

Comparing the adrenaline-Pirquet test with international PPD tuberculin tests. [2001.03]

A paired comparison of tuberculin skin test results in health care workers using 5 TU and 10 TU tuberculin. [2000.08]

Comparison testing of current (PPD-S1) and proposed (PPD-S2) reference tuberculin standards. [2000.04]

Instrumental measurement of the Mantoux test: differential effects of tuberculin and sodium lauryl sulphate on impedance response patterns in human skin. [2000]

Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. [1999.01.13]

Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. [1998.12]

Tuberculin sensitivity and skin lesions in children after vaccination with two batches of BCG vaccine. [1998.07]

Performance evaluation of tests used for tuberculin screening in adults: randomised comparison between Tine and Mono. [1998.06]

Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. [1997.09]

Use of automated reminders for tuberculin skin test return. [1997.05]

Comparative tuberculin reactivity to two protein derivatives. [1996.09]

The effects of prednisolone on the cutaneous tuberculin response in patients with corticosteroid-resistant bronchial asthma. [1996.02]

Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781). [1996]

Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity. [1995.06]

Can topical zinc accentuate tuberculin reactivity in the elderly? [1994.01]

Skin barrier function and dermal inflammation. An experimental study of transepidermal water loss after dermal tuberculin injection compared with SLS patch testing. [1993.11]

Topically applied verapamil hydrochloride inhibits tuberculin-induced delayed-type hypersensitivity reactions in human skin. [1992.12]

The role of inexperience in measuring tuberculin skin reaction (Mantoux test) by the pen or palpation technique. [1992.05]

Cimetidine as modulator of the cell-mediated immune response in vivo using the tuberculin skin test as parameter. [1990.02]

Lymphocyte proliferation in AIDS-related complex/Walter-Reed 5 patients: response to herpes simplex virus and tuberculin antigen and mitogen during intravenous immunoglobulin treatment. The ARC-IVIG Study Group. [1990]

Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin. [1989.08]

Rifampicin does not suppress the tuberculin reaction in man. [1987.11]

Well-designed clinical trials possibly related to Aplisol (Tuberculin)

Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans. [2012]

New regimens to prevent tuberculosis in adults with HIV infection. [2011.07.07]

Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. [2011.06]

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. [2011.05.07]

Language discordance and testing for latent tuberculosis infection among recent Asian and Latino immigrants. [2011.04]

Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. [2011]

Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania. [2010.11.10]

The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. [2010.11]

Neonatal BCG vaccination induces IL-10 production by CD4+ CD25+ T cells. [2010.11]

Language Discordance and Testing for Latent Tuberculosis Infection Among Recent Asian and Latino Immigrants. [2010.08.10]

Racial disparities in primary and reactivation tuberculosis in a rural community in the southeastern United States. [2010.06]

Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment. [2010.05.21]

Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. [2010.03.15]

Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. [2010.03.13]

Latent TB infection treatment acceptance and completion in the United States and Canada. [2010.02]

Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis. [2010.02]

Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis. [2009.02.23]

The effect of selenium supplementation on DTH skin responses in healthy North American men. [2009]

The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis. [2008.12]

Vaccination of cattle with Mycobacterium bovis BCG by a combination of systemic and oral routes. [2008.11]

Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. [2008.09]

Exercise training enhances in vivo tuberculosis purified protein derivative response in the elderly. [2008.06]

Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine. [2007.10]

Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. [2007.07.15]

Zinc cream and reliability of tuberculosis skin testing. [2007.07]

Educational outreach to promote screening for tuberculosis in primary care: a cluster randomised controlled trial. [2007.05.05]

Revaccination with Bacillus Calmette-Guerin (BCG) vaccine does not reduce morbidity from malaria in African children. [2007.02]

The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi. [2006.12]

Vitamin A supplementation increases ratios of proinflammatory to anti-inflammatory cytokine responses in pregnancy and lactation. [2006.06]

Prostaglandin E1 attenuates impairment of cellular immunity after cardiopulmonary bypass. [2006.04]

Influence of Bacillus Calmette-Guerin vaccination at birth and 2 months old age on the peripheral blood T-cell subpopulations [gamma/delta and alpha-beta T cell]. [2005.12]

Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens. [2005.11]

Efficacy of topical anesthetics to reduce pain in premature infants during eye examinations for retinopathy of prematurity. [2005.05]

Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU. [2005.03]

Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus? [2005.03]

INH preventive therapy among adult HIV-infected patients in Thailand. [2005.03]

Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. [2005.03]

Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles. [2004.06]

Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle. [2003.11.15]

High-dose inhaled fluticasone and delayed hypersensitivity skin testing. [2003.04]

Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. [2003.03]

Comparison of two needle sizes for subcutaneous administration of enoxaparin: effects on size of hematomas and pain on injection. [2002.09]

Immunotherapy with Mycobacterium vaccae and peripheral blood flow in long-treated leprosy patients, a randomised, placebo-controlled trial. [2002.09]

CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment. [2002.08.01]

Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. [2002.06]

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. [2002.04.20]

Collaboration with school nurses: improving the effectiveness of tuberculosis screening. [2001.12]

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. [2001.11.09]

Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. [2001.08.01]

A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. [2001.06.01]

Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. [2001.02]

[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group] [2000.07.01]

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group. [2000.03.15]

Infant BCG vaccination study in Lithuania. [1999.11]

Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method. [1999.09]

Safety and effectiveness of BCG vaccination in preterm babies. [1999.07]

Clinical reactogenicity of intradermal bacille Calmette-Guerin vaccination. [1999.04]

Monetary versus nonmonetary incentives for TB skin test reading among drug users. [1999.04]

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. [1999.03.11]

Comparison of the safety and immunogenicity of the lyophilized Merieux seed and the World Health Organization working reference BCG vaccines in school-aged children in Senegal. [1999.01]

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. [1998.12.24]

[Comparative study of the efficacy of two types of BCG vaccines administered in different doses] [1998.09]

Tuberculosis screening and compliance with return for skin test reading among active drug users. [1998.05]

The use of tetanus toxoid to elucidate the delayed-type hypersensitivity response in an older, immunized population. [1998]

A 14-mo zinc-supplementation trial in apparently healthy Chilean preschool children. [1997.12]

Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis. [1997.10]

Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults. [1997.10]

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. [1997.09.18]

Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy. [1997.09]

Strategies to increase adherence with tuberculosis test reading in a high-risk population. [1997.08]

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. [1997.06]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014